Eliminates drug affordability council, modifies financial rules

File SF5162 ("Eliminates drug affordability council, modifies financial rules") is before the Minnesota Legislature and has not been decided. Latest step (April 16, 2026): Introduction and first reading.

Minnesota file SF5162, before the Minnesota Legislature. Still to be decided as of 2026-04-16.

What it does

Drug price review council dissolved; no state negotiation Minnesota eliminates the Drug Affordability Advisory Council, removing a state mechanism that could have negotiated or reviewed high prescription drug prices on behalf of residents.

The bigger picture

Financial institution and health plan rules changed statewide Modifications to banking and health insurance regulations may affect lending practices, insurance product availability, and operational requirements for financial institutions and health plans doing business in Minnesota, though specifics depend on final bill language.

What to watch

Loss of state drug price advocacy; unclear regulatory impact Without the council, Minnesota residents lose a dedicated state voice in challenging high drug costs, and the full scope of financial/health plan rule changes is not yet detailed in public bill text.

Official summary

Drug Affordability Advisory Council elimination provision, various financial institutions and health plan provisions modifications, and appropriation

Read the official record for SF5162

See everything up for a vote · This week in Minnesota · See what we have filed with the clerk